tert-butyl 5-oxo-1,4,9-triazaspiro[5.5]undecane-9-carboxylate, 95.0%, 1g

2-Fluoro-4-methylbenzoic acid, 97.0%, 25g

(S)-3-Amino-3-(4-fluorophenyl)propan-1-ol hydrochloride, 95+%, 100mg

4-((5-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-yl)methyl)morpholine, 95.0%, 250mg

3-Fluoro-5-hydroxyphenylboronic acid, 95.0%, 25g

5-Methyl-4-nitro-3-isoxazolecarboxylic acid 10% in THF, 95.0%, 250mg

Methyl 4-(cyanoacetyl)benzoate, 95.0%, 5g

1-(7,8-Dihydronaphthalen-1-yl)ethan-1-one, 97%, 1g

2-Bromo-9,10-di(2-naphthyl)anthracene>98.0%(HPLC)1g

(2R,5R)-5-Benzyl-2-(tert-butyl)-3-methylimidazolidin-4-one, 97% 99%ee, 5g

(1R,2S,5S)-3-((S)-2-(3-(1-(tert-butylsulfonylmethyl)cyclohexyl)ureido)-3,3-dimethylbutanoyl)-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxylic acid, 98%, 100mg

3-(2-Bromophenyl)-9-phenyl-9H-carbazole>97.0%(GC)1g

(R)-1-(3-Fluorophenyl)ethanol, 95.0%, 10g